Risk for placental abruption following amniocentesis and chorionic villus sampling

Prenatal Diagnosis

Volumn 31, Issue 4, 2011, Pages 410-412

  Minna, Tikkanen ^a   Mika, Gissler ^b,c   Tiina, Luukkaala ^d,e   Marjo, Metsäranta ^a   Sture, Andersson ^a   Olavi, Ylikorkala ^a   Annukka, Ritvanen ^b   Vilho, Hiilesmaa ^a   Jorma, Paavonen ^a   Mika, Nuutila ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^d PIRKANMAA HOSPITAL DISTRICT   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Amniocentesis; Chorionic villus sampling; Fetal therapy; General cytogenetics; Genetic counselling; Placental abruption; Prenatal cytogenetics

Indexed keywords

ADULT; AMNIOCENTESIS; CHORION VILLUS SAMPLING; CONTROLLED STUDY; DATA BASE; DELIVERY; DISEASE CLASSIFICATION; FEMALE; FINLAND; FIRST TRIMESTER PREGNANCY; HUMAN; KARYOTYPING; LETTER; MAJOR CLINICAL STUDY; NEWBORN PERIOD; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE;

ABRUPTIO PLACENTAE; AMNIOCENTESIS; CASE-CONTROL STUDIES; CHORIONIC VILLI SAMPLING; COHORT STUDIES; FEMALE; HUMANS; MATERNAL AGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, MULTIPLE; RISK FACTORS;

EID: 79952735164     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2692     Document Type: Letter

References (14)

1. Cahill AG, Macones GA, Stamilio DM, Dicke JM, Crane JP, Odibo AO. 2009. Pregnancy loss rate after mid-trimester amniocentesis in twin pregnancies. Am J Obstet Gynecol 200: 257.e1-257.e6.
2. Cederholm M, Axelsson O. 1997. A prospective comparative study on transabdominal chorionic villus sampling and amniocentesis performed at 10-13 week's of gestation. Prenat Diagn 17(4): 311-317.
3. Cederholm M, Axelsson O, Sjöden PO. 1999. Women's knowledge, concerns and psychological reactions before undergoing an invasive procedure for prenatal karyotyping. Ultrasound Obstet Gynecol 114(4): 267-272.
4. Cederholm M, Haglund B, Axelsson O. 2003. Maternal complications following amniocentesis and chorionic villus sampling for prenatal karyotyping. BJOG 110: 392-399.
5. Eriksen G, Wohlert M, Ersbak V, Hvidman L, Hedegaard M, Skajaa K. 1991. Placental abruption. A case-control investigation. BJOG 98(5): 448-452.
6. Gissler M, Haukka J. 2004. Finnish health and social welfare registers in epidemiological research. Nor Epidemiol 14: 1-8.
7. Kramer MS, Usher RH, Pollack R, Boyd M, Usher S. 1997. Etiologic determinants of abruptio placentae. Obstet Gynecol 89: 221-226.
8. Nilsen RM, Vollset SE, Rasmussen SA, Ueland PM, Daltveit AK. 2008. Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study. Am J Epidemiol 167: 867-874.
9. Oyelese Y, Ananth CV. 2006. Placental abruption. Obstet Gynecol 108: 1005-1016.
10. Rhoads GG, Jackson LG, Schlesselman SE, et al. 1989. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 320(10): 609-617.
11. Tikkanen M, Gissler M, Metsäranta M, et al. 2009. Maternal deaths in Finland: focus on placental abruption. Acta Obstet Gynecol Scand 88: 1124-1127.
12. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. 2006. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 85: 700-705.
13. Tongsong T, Wanapirak C, Sirivatanapa P, Piyamongkol W, Sirichotiyakul S, Yampo A. 1998. Amniocentesis related fetal loss: a cohort study. Obstet Gynecol 92(1): 64-67.
14. Working Party of Amniocentesis. 1978. An assessment of the hazards of amniocentesis. Report to the Medical research Council by their working party on amniocentesis. BJOG 85(Suppl. 2): 1-41.